Nu Skin Reports 15% Revenue Decline in Q3 2025, Net Income Increases

Nu Skin Enterprises, Inc. reported a decline in financial performance for the third quarter of 2025, with revenue decreasing by 15% to $364.2 million compared to $430.1 million in the same period last year. For the first nine months of 2025, revenue also fell by 13% to $1.114 billion from $1.287 billion in the prior year. The company attributed these declines to ongoing macroeconomic challenges affecting consumer spending and customer acquisition, as well as a 0.4% negative impact from foreign currency fluctuations in the third quarter. Despite the revenue drop, net income for the third quarter increased to $17.1 million, up from $8.3 million in the prior-year period, largely due to a lower effective tax rate and reduced general and administrative expenses.

In terms of operational metrics, Nu Skin's customer base decreased by 10% year-over-year, with Paid Affiliates and Sales Leaders declining by 13% and 19%, respectively. The Americas segment saw a 17.1% revenue decline, while the Southeast Asia/Pacific and Mainland China segments experienced decreases of 5.4% and 19.8%, respectively. The company is focusing on business model optimization and plans to expand into the Indian market, although significant revenue from this initiative is not expected until 2026.

Strategically, Nu Skin completed the sale of its Mavely entity in January 2025 for $230 million, resulting in a pre-tax gain of approximately $176.2 million. This sale contributed positively to the company's financials, offsetting some of the revenue declines. The company also reported a $25.1 million impairment charge related to its BeautyBio asset group, reflecting a strategic shift in operations. Additionally, Nu Skin has been actively managing its expenses, with general and administrative costs decreasing by $10.8 million in the third quarter compared to the previous year.

Looking ahead, Nu Skin anticipates continued challenges in its markets but remains focused on enhancing its sales performance plan and launching new products. The company expects nominal revenue from its Prysm iO intelligent wellness platform in 2025, with a formal launch in India planned for the second half of 2026. The outlook remains cautious as the company navigates macroeconomic headwinds and works to stabilize its customer base and sales force engagement.